Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.
Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- Check4 days agoChange DetectedRemoved related topics 'Schizophrenia' and 'MedlinePlus Genetics' from the page's related topics section.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded related topic links: Schizophrenia and MedlinePlus Genetics to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check25 days agoChange DetectedRevision: v3.3.2 appears on the page and v3.2.0 is removed, indicating a minor version update. Core study content, endpoints, eligibility, and results remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check32 days agoChange DetectedThe page no longer displays the government funding notice and related topic links (Schizophrenia; MedlinePlus Genetics) that were present previously. These changes remove metadata/navigation items without affecting the core study details.SummaryDifference0.4%
- Check47 days agoChange DetectedThe page shows minor formatting and layout changes with no changes to the study's key content.SummaryDifference0.4%
- Check61 days agoChange DetectedAdded a new MedlinePlus Genetics topic on schizophrenia, expanding core content related to a medical condition.SummaryDifference0.1%
Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.